Ovarian Cancer Biomarker Discovery Based on Genomic Approaches

Ovarian cancer presents at an advanced stage in more than 75% of patients. Early detection has great promise to improve clinical outcomes. Although the advancing proteomic technologies led to the discovery of numerous ovarian cancer biomarkers, no screening method has been recommended for early dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung-Yun, Kim, Hee Seung, Suh, Dong Hoon, Kim, Mi-Kyung, Chung, Hyun Hoon, Song, Yong-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189448/
https://www.ncbi.nlm.nih.gov/pubmed/25337559
http://dx.doi.org/10.15430/JCP.2013.18.4.298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189448/
https://www.ncbi.nlm.nih.gov/pubmed/25337559
http://dx.doi.org/10.15430/JCP.2013.18.4.298

Ejemplares similares